Fundz

Intercure Continuing Its Medical Cannabis Consolidation Strategy, Announces Strategic Acquisition Of Cannomed Pharmacy Chain

PRIVATESep 02, 2021

Acquiring Company

InterCure (dba Canndoc)

Acquired Company

Cannomed Pharmacy Chain

OtherCommunity And LifestyleConsumer GoodsHealth CareAgriculture And FarmingFood And Beverage

Description

InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it has signed an agreement in which InterCure will purchase strategic assets from Cannomed (TASE: CNMD), an Israel-based company and owner of a pharmacy chain specializing in dispensing medical cannabis.

Quick answer

InterCure (dba Canndoc) is acquiring Cannomed Pharmacy Chain, announced September 2, 2021.

How much did InterCure (dba Canndoc) pay for Cannomed Pharmacy Chain?
The deal value was not disclosed.
What does InterCure (dba Canndoc) do?
InterCure (dba Canndoc) InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading cannabis company outside of North America.

Source: Fundz verified event record.

Other recent acquisitions in Community And Lifestyle and Consumer Goods

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at InterCure (dba Canndoc), and when

When InterCure (dba Canndoc) changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day InterCure (dba Canndoc) raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at InterCure (dba Canndoc), from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at InterCure (dba Canndoc). With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

InterCure (dba Canndoc)

About

InterCure (dba Canndoc) InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to maintain its position as Israel’s leading cannabis company as well as to drive further growth through global expansion. For more information, visit: http://www.intercure.co

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment InterCure (dba Canndoc) makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for InterCure (dba Canndoc)'s next move

Learn about Strategic plan

Frequently asked

Who acquired Cannomed Pharmacy Chain?

Cannomed Pharmacy Chain was acquired by InterCure (dba Canndoc). The deal was reported on September 2, 2021. InterCure (dba Canndoc) InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading cannabis company outside of North America. InterCure (dba Canndoc) is privately held and operates in Other.

When did InterCure (dba Canndoc) acquire Cannomed Pharmacy Chain?

InterCure (dba Canndoc)'s acquisition of Cannomed Pharmacy Chain was reported on September 2, 2021. InterCure Ltd. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Cannomed Pharmacy Chain do?

Cannomed Pharmacy Chain is the company acquired in this transaction. It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.